SJ Medical
SJ Medical
As the capital of the Kingdom of Saudi Arabia, Riyadh is at the forefront of the Middle East's healthcare transformation. Under the ambitious Saudi Vision 2030, the city is rapidly evolving into a global hub for medical excellence, particularly in the field of cardiovascular interventional science. As a leading Drug-Eluting Stents (DES) supplier in Riyadh, we recognize the critical demand for high-precision devices in prestigious institutions like the King Faisal Specialist Hospital & Research Centre and the Prince Sultan Cardiac Center.
The industrial landscape in Riyadh is shifting toward highly specialized medical manufacturing and supply chain localization. There is a profound emphasis on introducing Polymer-Free Sirolimus-Eluting Stents to reduce long-term inflammatory responses, a crucial factor considering the regional prevalence of metabolic conditions that complicate coronary interventions.
The evolution of Drug-Eluting Stents (DES) in the Riyadh market reflects a global shift toward bio-compatibility and rapid endothelization. Modern suppliers are no longer just distributors; they are partners in clinical outcomes. The latest trends in Riyadh's cardiology departments focus on thinner strut designs and targeted drug release profiles. These advancements are essential for treating complex lesions found in the Saudi patient demographic, which often presents with high calcification levels.
Furthermore, the integration of AI-assisted diagnostic tools alongside stenting procedures is gaining traction in Riyadh’s private and public healthcare sectors. Our stents, such as the Ht-Supreme Drug Coated Coronary Stent System, are designed to complement these digital health initiatives by providing predictable clinical results and superior deliverability through tortuous anatomy, making them a preferred choice for interventional cardiologists across the Kingdom.
Localized application scenarios in Riyadh include specialized coronary care units that require rapid response supply chains. By establishing a robust presence as a DES supplier, we ensure that life-saving technology is available exactly when the physician needs it, whether for elective procedures or emergency Percutaneous Coronary Interventions (PCI).
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We are now expanding our specialized services as a primary Drug-Eluting Stents (DES) supplier in Riyadh.
Access precision-engineered medical devices for your facility today.
Send Inquiry NowAs a prominent Drug-Eluting Stents (DES) supplier in Riyadh, SJ Medical understands that the cardiology market requires more than just products—it requires absolute trust. Our commitment to E-E-A-T principles means we invest heavily in clinical documentation and technical training for Riyadh-based surgeons. Whether you are performing a routine angioplasty or a complex multi-vessel intervention, our support team is available for pre-sales consultation and after-sales technical guidance.
We invite Riyadh's medical procurement officers and hospital administrators to explore our specialized vascular interventional systems. With certifications including CE and ISO 13485, we provide the peace of mind necessary for high-stakes cardiac care.
